ARCHIVES

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review

May 14, 1993

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983